1. Home
  2. COCP vs PTLE Comparison

COCP vs PTLE Comparison

Compare COCP & PTLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COCP
  • PTLE
  • Stock Information
  • Founded
  • COCP 2006
  • PTLE 2013
  • Country
  • COCP United States
  • PTLE Singapore
  • Employees
  • COCP N/A
  • PTLE N/A
  • Industry
  • COCP Biotechnology: Pharmaceutical Preparations
  • PTLE Oil Refining/Marketing
  • Sector
  • COCP Health Care
  • PTLE Energy
  • Exchange
  • COCP Nasdaq
  • PTLE Nasdaq
  • Market Cap
  • COCP 15.3M
  • PTLE 16.4M
  • IPO Year
  • COCP N/A
  • PTLE 2024
  • Fundamental
  • Price
  • COCP $1.60
  • PTLE $1.16
  • Analyst Decision
  • COCP Strong Buy
  • PTLE
  • Analyst Count
  • COCP 1
  • PTLE 0
  • Target Price
  • COCP $7.00
  • PTLE N/A
  • AVG Volume (30 Days)
  • COCP 17.1K
  • PTLE 316.6K
  • Earning Date
  • COCP 05-12-2025
  • PTLE 02-21-2025
  • Dividend Yield
  • COCP N/A
  • PTLE N/A
  • EPS Growth
  • COCP N/A
  • PTLE N/A
  • EPS
  • COCP N/A
  • PTLE 0.03
  • Revenue
  • COCP N/A
  • PTLE $108,126,091.00
  • Revenue This Year
  • COCP N/A
  • PTLE N/A
  • Revenue Next Year
  • COCP N/A
  • PTLE N/A
  • P/E Ratio
  • COCP N/A
  • PTLE $35.94
  • Revenue Growth
  • COCP N/A
  • PTLE 36.48
  • 52 Week Low
  • COCP $1.12
  • PTLE $1.11
  • 52 Week High
  • COCP $3.26
  • PTLE $15.78
  • Technical
  • Relative Strength Index (RSI)
  • COCP 57.48
  • PTLE N/A
  • Support Level
  • COCP $1.49
  • PTLE N/A
  • Resistance Level
  • COCP $1.74
  • PTLE N/A
  • Average True Range (ATR)
  • COCP 0.15
  • PTLE 0.00
  • MACD
  • COCP 0.04
  • PTLE 0.00
  • Stochastic Oscillator
  • COCP 63.79
  • PTLE 0.00

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

About PTLE PTL LTD Ordinary Shares

PTL Ltd is a holding company. Through its subsidiaries, it is an established bunkering facilitator providing marine fuel logistics services for vessel refuelling, primarily serving the Asia Pacific market. As a bunker facilitator, the Group's services mainly involve facilitating with its suppliers to supply fuel for the use by the customers' vessels at various ports along their voyages in the Asia Pacific region; arranging vessel refuelling activities at competitive pricing to the customers; offering trade credit to the customers for vessel refuelling; handling unforeseeable circumstances faced by the customers and providing contingency solutions to the customers in a timely manner; and handling disputes, mainly in relation to quality and quantity issues on marine fuel, if any.

Share on Social Networks: